Addex Therapeutics (ADXN) Invested Capital (2022 - 2025)
Historic Invested Capital for Addex Therapeutics (ADXN) over the last 3 years, with Q4 2024 value amounting to $11.0 million.
- Addex Therapeutics' Invested Capital rose 75545.03% to $11.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was $11.0 million, marking a year-over-year increase of 75545.03%. This contributed to the annual value of $11.0 million for FY2024, which is 76248.09% up from last year.
- According to the latest figures from Q4 2024, Addex Therapeutics' Invested Capital is $11.0 million, which was up 75545.03% from $1.3 million recorded in Q4 2023.
- In the past 5 years, Addex Therapeutics' Invested Capital registered a high of $11.0 million during Q4 2024, and its lowest value of $1.3 million during Q4 2023.
- Its 3-year average for Invested Capital is $5.8 million, with a median of $5.1 million in 2022.
- In the last 5 years, Addex Therapeutics' Invested Capital plummeted by 7467.81% in 2023 and then surged by 75545.03% in 2024.
- Quarter analysis of 3 years shows Addex Therapeutics' Invested Capital stood at $5.1 million in 2022, then plummeted by 74.68% to $1.3 million in 2023, then surged by 755.45% to $11.0 million in 2024.
- Its Invested Capital was $11.0 million in Q4 2024, compared to $1.3 million in Q4 2023 and $5.1 million in Q4 2022.